Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Taste Bud-Derived Stem Cells in Humans

View source ↗

Summary

A clinical trial is investigating taste bud–derived stem cells in humans for diabetes, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Diabetes | Status: RECRUITING